Adherence and Efficacy of Smoking Cessation Treatment Among Patients with COPD in China

References

• The GOLD Science Commitee. Global strategy for the diagnosis, management, and prevention of chronic pulmonary disease (2021 REPORT); 2020. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.0-16Nov20_WMV.pdf. Accessed November 18, 2020.
   Google Scholar
• World Health Organization. The top 10 causes of death; 2018. Available from: http://www.who.int/en/newsroom/fact-sheets/detail/the-top-10-causes-of-death. Accessed November 28, 2020.
   Google Scholar
• Shelley D, Tseng TY, Gonzalez M, et al. Correlates of adherence to varenicline among HIV+ smokers. Nicotine Tob Res. 2015;17(8):968–974. doi:10.1093/ntr/ntv068
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Stead LF, Koilpillai P, Fanshawe TR, et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286. doi:10.1002/14651858.CD008286.pub3
   PubMedGoogle Scholar
• Cahill K, Stevens S, Perera R, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:CD009329. doi:10.1002/14651858.CD009329.pub2
   PubMed Web of Science ®Google Scholar
• van Eerd EA, van der Meer RM, van Schayck OC, et al. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;8:CD010744. doi:10.1002/14651858.CD010744.pub2
   Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Solberg LI, Parker ED, Foldes SS, et al. Disparities in tobacco cessation medication orders and fills among special populations. Nicotine Tob Res. 2010;12(2):144–151. doi:10.1093/ntr/ntp187
   PubMed Web of Science ®Google Scholar
• Zeng F, Chen CI, Mastey V, et al. Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims. Clin Ther. 2011;33(2):225–234. doi:10.1016/j.clinthera.2011.02.013
   PubMed Web of Science ®Google Scholar
• Pacek LR, McClernon FJ, Bosworth HB. Adherence to pharmacological smoking cessation interventions: a literature review and synthesis of correlates and barriers. Nicotine Tob Res. 2018;20(10):1163–1172. doi:10.1093/ntr/ntx210
   PubMed Web of Science ®Google Scholar
• van Eerd EA, van Rossem CR, Spigt MG, et al. Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking. Respiration. 2015;90(3):211–219. doi:10.1159/000398816
   PubMed Web of Science ®Google Scholar
• Borrelli B, Hayes RB, Dunsiger S, et al. Risk perception and smoking behavior in medically ill smokers: a prospective study. Addiction. 2010;105(6):1100–1108. doi:10.1111/j.1360-0443.2010.02900.x
   PubMed Web of Science ®Google Scholar
• Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56(5):727–734. doi:10.1093/cid/cis933
   PubMed Web of Science ®Google Scholar
• Crawford G, Weisbrot J, Bastian J, et al. Predictors of varenicline adherence among cancer patients treated for tobacco dependence and its association with smoking cessation. Nicotine Tob Res. 2019;21(8):1135–1139. doi:10.1093/ntr/nty133
   PubMed Web of Science ®Google Scholar
• World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines; 1992.
   Google Scholar
• China National Health and Family Planning Commission. China clinical guidelines for tobacco cessation; 2015.
   Google Scholar
• Heatherton TF, Kozlowski LT, Frecker RC, et al. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–1127. doi:10.1111/j.1360-0443.1991.tb01879.x
   PubMedGoogle Scholar
• Sung YT, Wu JS. The visual analogue scale for rating, ranking and paired-comparison (VAS-RRP): a new technique for psychological measurement. Behav Res Methods. 2018;50(4):1694–1715. doi:10.3758/s13428-018-1041-8
   PubMed Web of Science ®Google Scholar
• Jones P. St. George’s respiratory questionnaire manual. 2009.
   Google Scholar
• Hjorthoj CR, Hjorthoj AR, Nordentoft M. Validity of timeline follow-back for self-reported use of cannabis and other illicit substances–systematic review and meta-analysis. Addict Behav. 2012;37(3):225–233. doi:10.1016/j.addbeh.2011.11.025
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811. doi:10.1097/00005650-200209000-00009
   PubMed Web of Science ®Google Scholar
• Browning KK, Wewers ME, Ferketich AK, et al. Adherence to tobacco dependence treatment among HIV-infected smokers. AIDS Behav. 2016;20(3):608–621. doi:10.1007/s10461-015-1059-1
   PubMed Web of Science ®Google Scholar
• Moulding HD, Friedman DP, Curtis M, et al. Revisiting anaplastic astrocytomas I: an expansive growth pattern is associated with a better prognosis. J Magn Reson Imaging. 2008;28(6):1311–1321. doi:10.1002/jmri.21593
   PubMed Web of Science ®Google Scholar
• Leischow SJ, Muramoto ML, Matthews E, et al. Adolescent smoking cessation with bupropion: the role of adherence. Nicotine Tob Res. 2016;18(5):1202–1205. doi:10.1093/ntr/ntv179
   PubMed Web of Science ®Google Scholar
• van Boven JF, Vemer P. Higher adherence during reimbursement of pharmacological smoking cessation treatments. Nicotine Tob Res. 2016;18(1):56–63. doi:10.1093/ntr/ntv064
   PubMed Web of Science ®Google Scholar
• Carroll AJ, Veluz-Wilkins AK, Blazekovic S, et al. Cancer-related disease factors and smoking cessation treatment: analysis of an ongoing clinical trial. Psychooncology. 2018;27(2):471–476. doi:10.1002/pon.4483
   PubMed Web of Science ®Google Scholar
• Gonzales D, Jorenby DE, Brandon TH, et al. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Addiction. 2010;105(11):2002–2013. doi:10.1111/j.1360-0443.2010.03058.x
   PubMed Web of Science ®Google Scholar
• Grandi SM, Eisenberg MJ, Joseph L, et al. Cessation treatment adherence and smoking abstinence in patients after acute myocardial infarction. Am Heart J. 2016;173:35–40. doi:10.1016/j.ahj.2015.12.003
   PubMed Web of Science ®Google Scholar
• Catz SL, Jack LM, McClure JB, et al. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011;13(5):361–368. doi:10.1093/ntr/ntr003
   PubMed Web of Science ®Google Scholar
• Hays JT, Leischow SJ, Lawrence D, et al. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine Tob Res. 2010;12(6):574–581. doi:10.1093/ntr/ntq047
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Carico E. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: functional analysis. Clin Respir J. 2020;14(1):29–34. doi:10.1111/crj.13096
   PubMed Web of Science ®Google Scholar
• Tøttenborg SS, Thomsen RW, Johnsen SP, et al. Determinants of smoking cessation in patients with COPD treated in the outpatient setting. Chest. 2016;150(3):554–562. doi:10.1016/j.chest.2016.05.020
   PubMed Web of Science ®Google Scholar
• Kupiainen H, Kinnula VL, Lindqvist A, et al. Successful smoking cessation in COPD: association with comorbidities and mortality. Pulm Med. 2012;2012:725024. doi:10.1155/2012/725024
   PubMedGoogle Scholar
• Okuyemi KS, Zheng H, Guo H, et al. Predictors of adherence to nicotine gum and counseling among African-American light smokers. J Gen Intern Med. 2010;25(9):969–976. doi:10.1007/s11606-010-1386-x
   PubMed Web of Science ®Google Scholar
• Vaz LR, Aveyard P, Cooper S, et al. The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: a secondary analysis of a randomized controlled trial. Nicotine Tob Res. 2016;18(10):1952–1959. doi:10.1093/ntr/ntw080
   PubMed Web of Science ®Google Scholar
• Balmford J, Borland R, Hammond D, et al. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res. 2011;13(2):94–102. doi:10.1093/ntr/ntq215
   PubMed Web of Science ®Google Scholar
• Hood NE, Ferketich AK, Paskett ED, et al. Treatment adherence in a lay health adviser intervention to treat tobacco dependence. Health Educ Res. 2013;28(1):72–82. doi:10.1093/her/cys081
   PubMed Web of Science ®Google Scholar
• Lewis JA, Senft N, Chen H, et al. Evidence-based smoking cessation treatment: a comparison by healthcare system. BMC Health Serv Res. 2021;21(1):33. doi:10.1186/s12913-020-06016-5
   PubMed Web of Science ®Google Scholar
• Yingst JM, Veldheer S, Hrabovsky S, et al. Reasons for non-adherence to nicotine patch therapy during the first month of a quit attempt. Int J Clin Pract. 2015;69(8):883–888. doi:10.1111/ijcp.12644
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Lionetto L, Ricci A, et al. Inter-individual variation in CYP2A6 activity and chronic obstructive pulmonary disease in smokers: perspectives for an early predictive marker. Biochim Biophys Acta Mol Basis Dis. 2021;1867(1):165990. doi:10.1016/j.bbadis.2020.165990
   PubMed Web of Science ®Google Scholar